期刊文献+

豁痰化瘀法对冠心病非PCI患者血浆光抑素-C水平的影响 被引量:1

Influence of eliminating phlegm and removing blood stasis therapy on light inhibition-C in plasma of patients with coronary heart disease without PCI
原文传递
导出
摘要 目的:观察豁痰化瘀中药对冠心病非PCI患者血浆光抑素-C(Cys C)水平的影响,确定豁痰化瘀中药对血管内粥样斑块的治疗作用。方法:80例患者随机分为对照组和治疗组,对照组采用单纯西药治疗,治疗组除西药外加用豁痰化瘀中药,观察两组临床疗效及血浆Cys C水平的变化。结果:两组治疗后Cys C均较治疗前降低(P<0.01),治疗组较对照组降低更显著(P<0.01)。结论:两种治疗方法均可降低Cys C水平,加用豁痰化瘀中药比单纯运用西药降低血浆Cys C水平效果明显。 Objective: To observe the influence of eliminating phlegm and removing blood stasis therapy on light inhibition-C in plasma of patients with coronary heart disease without PCI, and confirm the curative effect of drugs for eliminating phlegm and removing blood stasis in the treatment of intravascular atheromatous plaque. Methods: 80 patients were randomly divided into control group and treatment group. Patients in control group were treated with western medicine alone, and patients in treatment group were treated with drugs for eliminating phlegm and removing blood stasis based on the treatment of western medicine. The light inhibition-C level in plasma and clinical curative effect of patients in the two groups were observed, Results: The light inhibition-C level in plasma of patients of the two groups were both decreased after treatment, and the curative effect of treatment group was more significant compared with control group (P〈0.01). Conclusion: The two therapies could reduce the light inhibition-C level, and the curative effect in light inhibition-C level of combination with drugs for eliminating phlegm and removing blood stasis and western medicine is superior to that of western medicine alone.
作者 王玉晓
出处 《中华中医药杂志》 CAS CSCD 北大核心 2015年第8期2872-2873,共2页 China Journal of Traditional Chinese Medicine and Pharmacy
关键词 豁痰化瘀法 冠心病非PCI患者 光抑素-C Eliminating phlegm and removing blood stasis therapy Coronary heart disease patients without PCI Light inhibition-C
  • 相关文献

参考文献3

二级参考文献20

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1848
  • 2LIBBY P. Inflammation and atherosclerosis [ J ]. Circulation,2002, 5(9) : 1135 - 1143.
  • 3TANAKA A, SHIMADA K, SANO T, et al. Multiple plaque rup- ture and C reactive protein in acute myocardiai infarction [ J ]. J Am Coil Cardiol, 2005, 45(10) : 1594 - 1599.
  • 4SUN Y, CHIEN K L, HSU H C, et al. Use of serum homocys- teine to predict stroke, coronary heart disease and death inethnic Chinese 12 - year prospective cohort study[ J]. Circ J, 2009, 73 (8) : 1423 -1430.
  • 5TAGLIERI N, KOENIG W, KASKI J C. Cystatin C and cardio-vascula risk[J]. Clin Chem, 2009, 55 (12) : 1932 - 1943.
  • 6IX J H, SHLIPAK M G, CHERTOW G M, et al. Association of eystatin C with mortality cardiovascular events and incident heart failure among persons with coronary heart disease[ J]. Circulation, 2007, 115(2): 173-179.
  • 7BCNGTSSON E, TO F, GRUBB A, et al. Absence of the protease inhibitor cystatin - C in inflammatory cells results in larger plaque area in plaque regression of apoE - deficientmice[ J ]. Atheroscle- rosis, 2005, 180(1) : 45 -53.
  • 8ROSENSON R S, VRACAR GRABAR M, HELENOWSKI I. Lip- oprotein associated phospholipase A2 inhibition reduces gereration of oxidized fatty acids: LP - LPA2 reduces oxidized fatty avids [ JT. Cardiovasc Dru~s Ther. 2008.22( 1 ) : 55 - 58.
  • 9尹力,李广平,刘红梅,陈欣,刘恩照,刘彤,郑心田,许纲,徐延敏,周丽娟,何梅,李一丁,吴雷.硝苯地平控释片预防对比剂肾损害的随机化临床研究[J].中国介入心脏病学杂志,2009,17(2):103-104. 被引量:2
  • 10尹力,李广平,刘彤,刘红梅,陈欣,何梅,郑心田,刘恩照,周丽娟.普罗布考预防对比剂肾损害的随机化临床研究[J].中华心血管病杂志,2009,37(5):385-388. 被引量:25

共引文献85

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部